Bank Of Montreal Veracyte, Inc. Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$36.09 - $53.79 $11.1 Million - $16.5 Million	-306,200 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $168,304 - $250,283	4,725 Added 1.57%	306,200 $15.5 Million
Q2 2021 Aug 12, 2021	BUY	$32.94 - $56.62 $9.93 Million - $17.1 Million	301,475 New	301,475 $13.1 Million

308

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.07B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.